logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
A

Alimentary Pharmacology and Therapeutics

IF6.7
Papers11328
Citations24332
Journal Papers 12139
Publication Date
delete
Featured Cover
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-12-29
delete0
deleteOAAI
deleteSara Ellegaard Paaske; Simon Mark Dahl Baunwall; Tone Rubak; Nina Rågård; Jens Kelsen; Mette Mejlby Hansen; Anders Bergh Lødrup; Søren Lyhne; Emilie Glavind; Christa Marie Culmback Fernis; Stine Hald; Lise Tornvig Erikstrup; Lars Vinter-Jensen; Simon Lal; Susan Mikkelsen; Christian Erikstrup; Jens Frederik Dahlerup; Christian Lodberg Hvas
deleteShare
deleteSave
Stability of Classification Systems for Irritable Bowel Syndrome
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-12-25
delete0
deleteOAAI
deleteMais Khasawneh; Vivek C. Goodoory; Cho Ee Ng; Alexander C. Ford; Christopher J. Black
deleteShare
deleteSave
Meta-Analysis: High anti-HBs Titers are Associated with Significantly Reduced Risk of Hepatitis B Virus Reactivation During Rituximab Treatment
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-12-14
delete0
deleteOAAI
deleteShiva Poola; MaryKate Kratzer; Kerry Sewell; Zikun Yang; Hans L. Tillmann
deleteShare
deleteSave
Editorial: Beyond DNA Suppression: HBV RNA as a Predictor of Hepatocarcinogenesis
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-12-10
delete0
deleteOAAI
deleteToshifumi Tada
deleteShare
deleteSave
Editorial for ‘Review Article: Extending the Frontiers of Intestinal Ultrasound Knowledge, Performance, and Expansion’
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-12-02
delete0
deleteOAAI
deleteCameron Kendall; Akhilesh Swaminathan
deleteShare
deleteSave
Letter on ‘Clinical Trial: Effect of a 28-Day Low FODMAP Diet on Gastrointestinal Symptoms Associated With Endometriosis (EndoFOD)—A Randomised, Controlled Crossover Feeding Study’
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-25
delete0
deleteOAAI
deleteWancheng Zhao; Lei Yu; Jiao Wang
deleteShare
deleteSave
Letter on ‘Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis’
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-25
delete0
deleteOAAI
deleteMarlene Padilla-Lopez; María Carlota Londoño; Pinelopi Arvaniti
deleteShare
deleteSave
Letter: Affirming Cardiac Safety While Highlighting Areas for Further Research
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-25
delete0
deleteOAAI
deleteShanshan Huang; Jie Zhou
deleteShare
deleteSave
Editorial: High-Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer—Authors' Reply
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-24
delete0
deleteOAAI
deleteMonica E. W. Derks; Frank Hoentjen
deleteShare
deleteSave
Editorial: Efficacy of Pharmacological Compared With Dietary Therapy for Patients With Irritable Bowel Syndrome—It Is Nice to Have a Choice
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-24
delete0
deleteOAAI
deleteEmma P. Halmos; Peter R. Gibson
deleteShare
deleteSave
Editorial: Remission Ambition—How Far Should We Push in Older Adults? Authors' Reply
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-20
delete0
deleteOAAI
deleteCatherine Z. Tang; Adam S. Faye
deleteShare
deleteSave
Clinical Trial: Immunogenicity of Double-Dose Versus Standard-Dose of Hepatitis B Virus Vaccine in Inflammatory Bowel Disease
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-20
delete0
PREAI
deleteAnupam Kumar Singh; Roop Kishor Soni; Vaneet Jearth; Ashutosh Ishan Yadav; Chhagan Lal Birda; Abhirup Chatterjee; Jimil Shah; Ritin Mohindra; Amol N. Patil; Vikas Suri; Vishal Sharma; Arun Kumar Sharma; Usha Dutta
deleteShare
deleteSave
Editorial: Comparable Hepatic Fibrosis Risk Demands Equal Vigilance in Lean and Non-Lean Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease—Authors' Reply
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-11
delete0
deleteOAAI
deleteKaleb Tesfai; Luis Antonio Díaz; Veeral Ajmera
deleteShare
deleteSave
Letter: Refining Mortality Estimates in Severe Alcohol-Associated Hepatitis—Addressing Heterogeneity and Prognostic Assessment
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-07
delete0
deleteOAAI
deleteShupeng Zhao; Leilei Zhai; Ping Yao
deleteShare
deleteSave
Letter: Refining Mortality Estimates in Severe Alcohol–Associated Hepatitis—Addressing Heterogeneity and Prognostic Assessment. Authors' Reply
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-07
delete0
deleteOAAI
deleteFrancisco Idalsoaga; Luis Antonio Diaz; Mohammad Qasim Khan; Juan Pablo Arab
deleteShare
deleteSave
Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and Death
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-05
delete0
deleteOAAI
deleteMathias Jachs; Tânia Carvalho; Benedikt Simbrunner; Georg Semmler; Lukas Hartl; Lorenz Balcar; Benedikt Silvester Hofer; Paul Thöne; Nina Dominik; Georg Kramer; Christian Sebesta; Michael Schwarz; David Bauer; Albert F. Stättermayer; Matthias Pinter; Michael Trauner; Thomas Reiberger; Mattias Mandorfer
deleteShare
deleteSave
Systematic Review: Stigma Associated With Inflammatory Bowel Disease
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-04
delete0
PREAI
deleteSuprabhat Giri; Sidharth Harindranath; Sanjay Chandnani; Anuraag Jena; Vishal Sharma; Shaji Sebastian
deleteShare
deleteSave
Letter: Safety and Tolerability of Injectable Extended Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol-Associated Liver Disease
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-04
delete0
deleteOAAI
deleteXing Bai; Ziqi Sui; Yunmeng Nie
deleteShare
deleteSave
Letter: Safety and Tolerability of Injectable Extended-Release Naltrexone for the Management of Alcohol Use Disorder in Advanced Alcohol-Associated Liver Disease—Authors' Reply
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-04
delete0
deleteOAAI
deleteLuis Antonio Díaz; Rohit Loomba
deleteShare
deleteSave
Meta-Analysis: Improvement of Bowel Urgency With Advanced Therapies for Inflammatory Bowel Disease
deleteAlimentary Pharmacology & Therapeutics
IF6.7
delete2025-11-04
delete0
PREAI
deletePurab Patel; Peter Belesiotis; Nitin Shiv Rai; Yuhong Yuan; Neeraj Narula; Christopher Ma; Maria Cino; Alexa Sasson; Vipul Jairath; Parul Tandon
deleteShare
deleteSave